| gen: 2026/07/31:18:10 in 4 min 47.3 sec (old)bias: 8 (Unknown) |
| type: lolsquality: 35 |
| pts: 0 |
#healthcare#diabetes#integrative med#research#china#type1diabetes#insulin#shenzhen#shanghai#prnewswire
A team in China worked medicine with flair, blending East and West into integrative care; They patched leaky guts, calmed autoimmune ruts, and thirty type 1s ditched insulin—pump-and-circumstance rare.
 | author: | Unknown | institution: | PR Newswire | ¿porque no los dos? |
| tl;dr | A paid PR Newswire release on Yahoo Finance claims a Chinese medical team at Shanghai Fudan Group Shenzhen Hong Sung Hospital helped 30 type 1 diabetes patients discontinue insulin through “integrative medicine,” describing “functional remission” and immune/gut mechanisms. The piece frames this as a major breakthrough and outlines a treatment philosophy, but provides few verifiable study details (trial design, outcomes, duration, safety, independent confirmation, or peer-reviewed publication). | ||||
| deeper: | The content is promotional and one-sided: it highlights dramatic outcomes and “breakthrough” language without critical context or independent validation. Key scientific specifics are missing (patient selection, baseline characteristics, objective endpoints, follow-up length, adverse events, and whether insulin independence was sustained). It appears as a paid press release, which increases incentive to persuade rather than scrutinize. Quality is limited by lack of sourcing, peer-reviewed citations, and absence of counterpoints or expert verification. | ||||
media: | |||||
Please log in to comment